Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 159
Selected: 0
NCT IDTitle
NCT00947466A Study to Characterize the Pharmacokinetics and Tolerability of Buprenorphine Patches in Children With Moderate to Severe Mouth Pain
NCT02072200Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE)
NCT01526694Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM
NCT01457144Study of Mantle Cell Lymphoma Treatment by RiBVD
NCT01167699Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT02431624An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion
NCT03967327A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain
NCT03768466Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment
NCT00563056An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma
NCT01701076Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma
NCT01675622Immediate-Release Oxycodone Capsules Study in Cancer Pain
NCT02237261Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma
NCT00963534Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.
NCT01885182Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain
NCT02094560CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors
NCT01961271Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain
NCT02403713A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers
NCT03348917The Effect of Skin Cleansers on the Skin Surface Microbiome
NCT01313780A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients
NCT02063139Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years.
NCT01439100A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain
NCT01423032Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)
NCT02452112Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated Pain
NCT01376401Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma
NCT03150602A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy
NCT02160067A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches
NCT00412152Oxycodone-naloxone in Relieving Opioid-related Constipation
NCT01675531A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
NCT00626600A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion
NCT05072249European Cohort Study of the Effectiveness of Take Home Naloxone
NCT02863263Efficacy and Safety of MedifoamⓇ and BetafoamⓇ in Pressure Ulcer
NCT03492775First Line Therapy of Advanced Stage Follicular Lymphoma in Patients < 60 Years Not Eligible fo Standard Immunochemotherapy and in All Patients ≥ 60 Years
NCT00801216High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement
NCT01083485OXN PR Compared to OXY PR in Subjects With Postoperative Pain After Knee Arthroplasty
NCT02576496Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies
NCT01983111Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION)
NCT03187210Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas
NCT01812733Non-interventional Study Comparing Targiniq and Oxycodone/Laxatives
NCT01167127Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT01563614A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain
NCT02519387Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity
NCT01438567A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
NCT02326454A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
NCT03398330OTR Tablet 40 mg Fed-state Bioequivalence Study
NCT00412100Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation
NCT04053608Human Physiology and Self-Reported Pain Score
NCT02321397To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
NCT03398278OTR Tablet 40 mg Fasted-state Bioequivalence Study
NCT02880475OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant Patients
NCT02126709The Efficacy and Safety of 3% Povidone-Iodine in Acne Therapy